| 标题 |
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1G2032R resistance mutation in NSCLC: The first-in-human phase 1 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Cell 作者:Yuxiang Ma; Jinhui Xue; Fangfang Gao; Yunpeng Yang; Yuanyuan Zhao; et al 出版日期:2026-04-23 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)